Patients with higher Gleason scores (ISUP GG3 compared to GG1–2) exhibited significantly worse progression‐free survival ( p = 0.0004) and poorer salvage‐free survival, although the latter did not reach statistical significance ( p = 0.08). 3.5 Predictors of pathological progression Univariate analysis demonstrated that more aggressive histology and various markers of unfavourable PSA dynamics were significantly associated with an increased likelihood of pathological progression (Table 4 ).
← all excerpts
Oncological outcomes post focal low-dose-rate brachytherapy in low-intermediate risk prostate cancer.
1
0.0800
0.0800